Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0IA5O
|
||||
Former ID |
DIB011261
|
||||
Drug Name |
GSK-2241658A
|
||||
Synonyms |
NY-ESO-1 ASCI (melanoma), GSK; Recombinant NY-ESO-1 antigen immunotherapeutic vaccine (melanoma), GlaxoSmithKline; 2241658A
|
||||
Drug Type |
Vaccine
|
||||
Indication | Melanoma [ICD9: 172; ICD10:C43] | Phase 1 | [523193] | ||
Company |
GlaxoSmithKline plc
|
||||
Target and Pathway | |||||
Target(s) | NY-ESO-1 | Target Info | [523193] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.